Gene · 4841
NIH grants1,250
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,250
Download this page as JSON| Grant | Title | NONO papers | Newest fiscal year |
|---|---|---|---|
| R01AR060733 | Transcriptome processing networks in skeletal muscle: mechanisms and functions | 1 | 2023 |
| R01CA095641 | Chromatin's Role in Repair of Radiation-induced Damage | 1 | 2023 |
| R01CA121192 | Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia | 1 | 2023 |
| R01CA166413 | Mechanisms and Function of Autophagy in Cancer | 1 | 2023 |
| R01CA203737 | Targeting HER2-low breast cancer with 17p loss | 1 | 2023 |
| R01CA230453 | Targeting DNA repair in KRAS mutated lung cancer by chemical screening | 1 | 2023 |
| R01CA230561 | Targeting oncogenes for hepatocellular carcinoma | 1 | 2023 |
| R01CA232017 | NanoOptogenetic immunotherapy for B cell lymphoma | 1 | 2023 |
| R01CA233201 | An improved IL-24 gene-based therapeutic for cancer | 1 | 2023 |
| R01CA233585 | Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer | 1 | 2023 |
| R01CA236118 | Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer | 1 | 2023 |
| R01CA236949 | Role of SETD5 in Chromatin Regulation and Tumorigenesis | 1 | 2023 |
| R01CA240004 | A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma | 1 | 2023 |
| R01CA247365 | Chemical Biology of the Control of Neddylation by DCN1 | 1 | 2023 |
| R01DK052913 | Epigenomic Regulation in Pancreatic Cell Growth | 1 | 2023 |
| R01DK068437 | Postprandial Vitamin A | 1 | 2023 |
| R01DK120387 | Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodes | 1 | 2023 |
| R01DK120523 | Regulation of beta-cell homeostasis by DNA methylation and hydroxymethylation. | 1 | 2023 |
| R01GM084089 | Regulation of alternative cleavage and polyadenylation | 1 | 2023 |
| R01GM130759 | Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/grants?page=18